09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

carcinogenic potency may decline in homologues more chlorinated than TCDD. It was therefore<br />

assumed that PCDDs and PCDFs that are not chlorinated on the 2,3,7,8 positions or do not have at<br />

least one ring position open are noncarcinogenic. Additionally, it was also considered that the<br />

2,3,7,8-isomer PentaCDD has a carcinogenic potency equivalent to TCDD, and that 2,3,7,8-isomer<br />

HeptaCDD is equivalent in carcinogenic potency to 2,3,7,8-isomer HexaCDD. The potencies for the<br />

homologous PCDDs were also used for the PCDFs. Using this approach, the potency of a given<br />

concentration of PCDDs would be 2% of the potency of TCDD. The potency of a mixture of PCDFs<br />

would be 3% of the potency of TCDD.<br />

Since 1986, another toxicity equivalency factor (TEF) scheme was developed during an international<br />

symposium (NATO/CCMS, 1988a,b), and it was adopted by US EPA (US EPA, 1989) and the<br />

Department of Toxic Substances Control (DTSC) (DTSC, 1992). The international scheme, referred<br />

to as ITEFs, is based on experimental cancer and noncancer data for many 2,3,7,8-PCDDs and<br />

2,3,7,8-PCDFs and on the assumption that the mechanism of all PCDD/PCDF-related biologic effects<br />

are based on initial binding to a specific protein, the Ah receptor. Because the ITEF scheme<br />

incorporates more experimental data from cancer and noncancer studies for more PCDDs/PCDFs than<br />

does the CTEF scheme, the replacement of the CTEFs by the ITEFs is appropriate for use in risk<br />

assessment. This approach also increases uniformity among Cal/EPA guidelines. The TEFs contained<br />

in the dioxin TAC (CDHS, 1986) document and the ITEFs are listed in Table 8. A detailed discussion<br />

of the ITEFs and their use can be found in Appendix A of this document. The cancer unit risks and<br />

potency factors for chlorinated dibenzo-p-dioxins and dibenzofurans listed in this chemical summary and<br />

in the Hot Spots Unit Risk and Cancer Potency Values table have been generated by applying the<br />

appropriate ITEFs to the cancer unit risk and potency factor for 2,3,7,8-TCDD calculated in the dioxin<br />

TAC document.<br />

Table 8: Toxicity equivalency factors for chlorinated dibenzo-p-dioxins and<br />

dibenzofurans (relative to 2,3,7,8-TCDD)<br />

Compound<br />

(Dioxins)<br />

Congeners CDHS -TEFs ITEFs<br />

Mono-, Di-, Tri-CDDs 0 0<br />

TetraCDD 2,3,7,8- (1.0) (1.0)<br />

others 0<br />

PentaCDD 2,3,7,8- 1.0 0.5<br />

others 0 0<br />

HexaCDD 2,3,7,8- 0.03 0.1<br />

others 0 0<br />

HeptaCDD 2,3,7,8- 0.03 0.01<br />

others 0 0<br />

OctaCDD 0 0.001<br />

182

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!